A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Show other versions (1)

<p>Abstract</p> <p>Background</p> <p>There are no previous reports of paliperidone palmitate's (PP) long term tolerability or pharmacokinetics of the highest dose in patients with schizophrenia. This study evaluates safety and tolerability, as well as pharmacokinet...

Full description

Bibliographic Details
Main Authors: Coppola Danielle, Liu Yanning, Gopal Srihari, Remmerie Bart, Samtani Mahesh N, Hough David W, Nuamah Isaac, Sulaiman Ahmad, Pandina Gahan
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Psychiatry
Subjects:
Antipsychotics
Paliperidone palmitate
Pharmacokinetics
Schizophrenia
Safety
Long-term therapy
Online Access:http://www.biomedcentral.com/1471-244X/12/26

Internet

http://www.biomedcentral.com/1471-244X/12/26

Similar Items